| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diagnostic assessment | 2 | 1 | |
| Adenocarcinoma (non-small cell lung cancer) | 1 | 0 | |
| Lung carcinoid tumor | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Difficulty walking | 1 | |
| Generalized weakness (asthenia) | 1 | |
| Pain | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 0 |